Ethic Inc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.6M Sell
268,319
-529
-0.2% -$56.4K 0.51% 21
2025
Q1
$27.2M Buy
268,848
+26,919
+11% +$2.73M 0.55% 21
2024
Q4
$21.6M Buy
241,929
+46,946
+24% +$4.19M 0.44% 30
2024
Q3
$13.4M Sell
194,983
-21,479
-10% -$1.47M 0.34% 52
2024
Q2
$16.7M Buy
216,462
+21,479
+11% +$1.65M 0.39% 39
2024
Q1
$13.4M Buy
194,983
+19,001
+11% +$1.3M 0.34% 52
2023
Q4
$10.2M Buy
175,982
+10,646
+6% +$615K 0.3% 62
2023
Q3
$8.73M Buy
165,336
+12,470
+8% +$658K 0.31% 63
2023
Q2
$8.27M Buy
152,866
+6,241
+4% +$338K 0.31% 64
2023
Q1
$7.34M Buy
146,625
+17,655
+14% +$883K 0.3% 74
2022
Q4
$5.97M Buy
128,970
+13,082
+11% +$605K 0.32% 69
2022
Q3
$4.49M Buy
115,888
+18,959
+20% +$734K 0.3% 76
2022
Q2
$3.61M Buy
96,929
+18,281
+23% +$681K 0.25% 99
2022
Q1
$3.48M Buy
78,648
+11,979
+18% +$531K 0.24% 100
2021
Q4
$2.83M Buy
66,669
+6,895
+12% +$293K 0.22% 114
2021
Q3
$2.59M Buy
59,774
+7,797
+15% +$338K 0.27% 89
2021
Q2
$2.22M Buy
51,977
+18,058
+53% +$772K 0.27% 83
2021
Q1
$1.31M Buy
33,919
+14,693
+76% +$568K 0.23% 105
2020
Q4
$691K Sell
19,226
-1,979
-9% -$71.1K 0.18% 139
2020
Q3
$810K Buy
21,205
+14,449
+214% +$552K 0.31% 84
2020
Q2
$237K Buy
+6,756
New +$237K 0.13% 207
2020
Q1
Sell
-5,445
Closed -$246K 214
2019
Q4
$246K Buy
+5,445
New +$246K 0.18% 179